BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 27831638)

  • 1. Aescin-based topical formulation to prevent foot wounds and ulcerations in diabetic microangiopathy.
    Hu S; Belcaro G; Dugall M; Hosoi M; Togni S; Maramaldi G; Giacomelli L
    Eur Rev Med Pharmacol Sci; 2016 Oct; 20(20):4337-4342. PubMed ID: 27831638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aescin: microcirculatory activity. Effects of accessory components on clinical and microcirculatory efficacy.
    Luzzi R; Feragalli B; Belcaro G; Cesarone MR; Cornelli U; Dugall M; Hosoi M
    Panminerva Med; 2011 Sep; 53(3 Suppl 1):51-5. PubMed ID: 22108477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Product evaluation of Ureadin Rx Db (ISDIN) for prevention and treatment of mild-to-moderate xerosis of the foot in diabetic patients. Prevention of skin lesions due to microangiopathy.
    Ciammaichella G; Belcaro G; Dugall M; Hosoi M; Luzzi R; Ippolito E; Cesarone MR
    Panminerva Med; 2012 Dec; 54(1 Suppl 4):35-42. PubMed ID: 23241933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microvascular alterations in diabetic microangiopathy: topical treatment with Essaven gel--a placebo-controlled, randomized study.
    Incandela L; Belcaro G; Cesarone MR; De Sanctis MT; Griffin M
    Angiology; 2001 Dec; 52 Suppl 3():S35-41. PubMed ID: 11775647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of diabetic microangiopathy with pycnogenol: A prospective, controlled study.
    Cesarone MR; Belcaro G; Rohdewald P; Pellegrini L; Ledda A; Vinciguerra G; Ricci A; Gizzi G; Ippolito E; Fano F; Dugall M; Cipollone G; Acerbi G; Cacchio M; Del Boccio G; Di Renzo A; Stuard S; Corsi M
    Angiology; 2006; 57(4):431-6. PubMed ID: 17022378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential role of curcumin phytosome (Meriva) in controlling the evolution of diabetic microangiopathy. A pilot study.
    Appendino G; Belcaro G; Cornelli U; Luzzi R; Togni S; Dugall M; Cesarone MR; Feragalli B; Ippolito E; Errichi BM; Pellegrini L; Ledda A; Ricci A; Bavera P; Hosoi M; Stuard S; Corsi M; Errichi S; Gizzi G
    Panminerva Med; 2011 Sep; 53(3 Suppl 1):43-9. PubMed ID: 22108476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-week topical treatment with Essaven gel in patients with diabetic microangiopathy--a placebo-controlled, randomized study.
    Cesarone MR; Incandela L; Belcaro G; De Sanctis MT; Ricci A; Griffin M
    Angiology; 2001 Dec; 52 Suppl 3():S43-8. PubMed ID: 11775648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased transcutaneous oxygen tension in the skin dorsum over the foot in patients with diabetic foot disease in response to the topical use of an emulsion of hyperoxygenated Fatty acids.
    Lázaro-Martínez JL; Sánchez-Ríos JP; García-Morales E; Cecilia-Matilla A; Segovia-Gómez T
    Int J Low Extrem Wounds; 2009 Dec; 8(4):187-93. PubMed ID: 19825855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the local effects of vitamin E (E-Mousse) on free radicals in diabetic microangiopathy: a randomized, controlled trial.
    Ruffini I; Belcaro G; Cesarone MR; Geroulakos G; Di Renzo A; Milani M; Coen L; Ricci A; Brandolini R; Dugall M; Pomante P; Cornelli U; Acerbi G; Corsi M; Griffin M; Ippolito E; Bavera P
    Angiology; 2003; 54(4):415-21. PubMed ID: 12934761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of topical treatment with aescin + essential phospholipids gel in venous insufficiency and hypertension.
    Ruffini I; Belcaro G; Cesarone MR; Dugall M
    Angiology; 2004; 55 Suppl 1():S19-21. PubMed ID: 15156253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microcirculatory efficacy of topical treatment with aescin + essential phospholipids gel on transcutaneous PO2 in venous insufficiency.
    Cesarone MR; Belcaro G; Ippolito E; Ricci A; Ruffini M; Dugall M
    Angiology; 2004; 55 Suppl 1():S7-10. PubMed ID: 15156250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early detection of microcirculatory impairment in diabetic patients with foot at risk.
    Zimny S; Dessel F; Ehren M; Pfohl M; Schatz H
    Diabetes Care; 2001 Oct; 24(10):1810-4. PubMed ID: 11574447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Four-week treatment with Essaven gel in diabetic microangiopathy--a placebo-controlled, randomized study.
    De Sanctis MT; Cesarone MR; Incandela L; Belcaro G; Ricci A; Griffin M
    Angiology; 2001 Dec; 52 Suppl 3():S49-55. PubMed ID: 11775649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microcirculatory efficacy of topical treatment with aescin + essential phospholipids gel in venous insufficiency and hypertension: new clinical observations.
    Belcaro G; Cesarone MR; Dugall M
    Angiology; 2004; 55 Suppl 1():S1-5. PubMed ID: 15156249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meriva®, a lecithinized curcumin delivery system, in diabetic microangiopathy and retinopathy.
    Steigerwalt R; Nebbioso M; Appendino G; Belcaro G; Ciammaichella G; Cornelli U; Luzzi R; Togni S; Dugall M; Cesarone MR; Ippolito E; Errichi BM; Ledda A; Hosoi M; Corsi M
    Panminerva Med; 2012 Dec; 54(1 Suppl 4):11-6. PubMed ID: 23241930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of topical treatment with aescin + essential phospholipids gel in a microcirculatory model of venous insufficiency.
    Belcaro G; Cesarone MR; Dugall M
    Angiology; 2004; 55 Suppl 1():S15-8. PubMed ID: 15156252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elastic stockings in diabetic microangiopathy. Long-term clinical and microcirculatory evaluation.
    Belcaro G; Laurora G; Cesarone MR; Pomante P
    Vasa; 1992; 21(2):193-7. PubMed ID: 1621441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of microcirculatory techniques in patients with diabetic foot syndrome.
    Lawall H; Amann B; Rottmann M; Angelkort B
    Vasa; 2000 Aug; 29(3):191-7. PubMed ID: 11037717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of diabetic microangiopathy and edema with HR (Paroven, Venoruton; 0-(beta-hydroxyethyl)-rutosides): a prospective, placebo-controlled, randomized study.
    Incandela L; Cesarone MR; DeSanctis MT; Belcaro G; Dugall M; Acerbi G
    J Cardiovasc Pharmacol Ther; 2002 Jan; 7 Suppl 1():S11-5. PubMed ID: 12011967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of treatment of diabetic microangiopathy with total triterpenic fraction of Centella asiatica: a clinical prospective randomized trial with a microcirculatory model.
    Cesarone MR; Incandela L; De Sanctis MT; Belcaro G; Bavera P; Bucci M; Ippolito E
    Angiology; 2001 Oct; 52 Suppl 2():S49-54. PubMed ID: 11666124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.